...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

NBB,,,as noted in my previous post DMcC has a ton of exeprience and talent sitting next to him with the management teams on both and the BoDs. Reading the bios on all the members one would assume we should be top drawer when it comes to working within the BioPharma scene!!,,,Why nothing happens is the quandry!!,,Its as if it is all orchestrated to be so!

Share
New Message
Please login to post a reply